Opinions of Healthcare Providers About a European Neuromodulation Register

Opinions of Healthcare Providers About a European Neuromodulation Register: an Online Survey

The goal of this online survey is to gain further insights in the needs and burden for a European registry for neuromodulation, according to healthcare providers.

Study Overview

• Status: Recruiting
• Conditions: Survey; Neuromodulation; Registry
• Intervention / Treatment: Behavioral: Filling in an online survey

• Study Type: Observational
• Enrollment (Estimated): 100

Contacts and Locations

• Study Contact: Name: Maarten Moens; Phone Number: +3224775514; Email: stimulusresearchgroup@gmail.com
• Study Contact Backup: Name: Lisa Goudman; Phone Number: +3224775514; Email: stimulusresearchgroup@gmail.com

Study Locations

• Germany
  • Hamburg, Germany
    • Recruiting
    • Congres Center
    • Contact: Maarten Moens

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

In this study male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses) will be eligible to complete the survey. The survey will be spread at the 3ʳᵈ Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg from 31/8/2023 to 2/9/2023.

Description

Inclusion Criteria:

• Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses).

Exclusion Criteria:

• Not involved in management of chronic pain through neuromodulation.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Healthcare professionals involved in neuromodulation	Behavioral: Filling in an online survey; Professionals are asked to complete questions regarding 1) the degree of current participation in a registry, 2) the need for a European registry, 3) the items that should be collected and 4) access to the European registry.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Healthcare providers their current degree of participation in a registry for neuromodulation.	Degree of participation in a registry for neuromodulation (question).	Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.
Healthcare providers their need for a European registry.	Underlying reasons on why a European registry is needed, or not needed (question).	Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.
Items that should be included in a registry for neuromodulation, according to healthcare providers.	Items that should be collection within a registry, evaluated with a multiple choice question.	Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.
Access regulations to European registry for neuromodulation, according to healthcare providers.	Access regulations, evaluated with a multiple choice question.	Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.

Collaborators and Investigators

• Sponsor: Moens Maarten
• Collaborators: Vrije Universiteit Brussel

Study record dates

Study Major Dates

• Study Start (Actual): August 31, 2023
• Primary Completion (Estimated): September 2, 2023
• Study Completion (Estimated): September 2, 2023

Study Registration Dates

• First Submitted: August 26, 2023
• First Submitted That Met QC Criteria: September 2, 2023
• First Posted (Actual): September 11, 2023

Study Record Updates

• Last Update Posted (Actual): September 11, 2023
• Last Update Submitted That Met QC Criteria: September 2, 2023
• Last Verified: September 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: PROLOGUE

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No